


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.96%
-0.88%
+11.82%
+2.21%
DVAX
Dynavax
$15.62
Strengths

Earnings are forecast to grow

Expands stock buyback program
DVAX Price Performance
$10.79 (+44.76%)
$10.06 (+55.27%)
$10.5 (+48.76%)
$13.05 (+19.69%)
DVAX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

DVAX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
DVAX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DVAX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
DVAX
Dynavax
15.62
+0.13%
CGBD
TCG BDC
12.93
+0.94%
BURU
Nuburu
0.18
-3.11%
SLG
SL Green Realty
48.62
+1.21%
ORI
Old Republic Internationa
43.32
+0.74%
What is DVAX current stock price?
What are DVAX stock strengths?
What is DVAX Risk Level?
What is DVAX market cap and volume?
What is DVAX current Stock IQ?
Should I buy DVAX stock right now?
Is DVAX a Strong Buy right now?
What does a 'Strong Buy' rating mean for DVAX?
What does a 'Strong Sell' rating mean for DVAX?
What factors influence DVAX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.96%
-0.88%
+11.82%
+2.21%
DVAX
Dynavax
Current Price
$15.62
DVAX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program
Recently Viewed
DVAX
Dynavax
15.62
+0.13%
CGBD
TCG BDC
12.93
+0.94%
BURU
Nuburu
0.18
-3.11%
SLG
SL Green Realty
48.62
+1.21%
ORI
Old Republic Internationa
43.32
+0.74%

DVAX Price Performance
$10.79 (+44.76%)
$10.06 (+55.27%)
$10.5 (+48.76%)
$13.05 (+19.69%)
DVAX Analysts Opinion
DVAX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow
![]()
DVAX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DVAX Street Sentiment is extremely bullish and have positive views on the near-term outlook
DVAX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
DVAX Latest Analysis
Dynavax Technologies (DVAX) Price Target Increased by 15.66% to 24.48. The average one-year price target for Dynavax Technologies (NasdaqGS:DVAX) has been revised to $24.48 / share. This is an increase of 15.66% from the prior estimate of $21.16 dated December 18 2025. The price target is an average of many targets provided by a
Wed Jan 14, 2026
Dynavax gains on disclosure another bidder interested after deal announced.
Mon Jan 12, 2026
Where is Sanofi (SNY) Headed According to Wall Street?. Sanofi (NASDAQ:SNY) is one of the best affordable healthcare stocks to buy now. Sanofi (NASDAQ:SNY) announced on December 24 an agreement to acquire Dynavax Technologies Corporation which is a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) and a differentiated shingles vaccine candidate. Dynavaxs adult hepatitis B vaccine HEPLISAV-B is marketed in [….]
Tue Dec 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
DVAX Stock trends
DVAX Stock performance
DVAX Stock analysis
DVAX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.